|Podcasts|October 4, 2022
Transforming CMC Dossier Creation
Author(s)Dassault Systèmes BIOVIA
Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
2
New Targets for Clinical Trials in the European Union
3
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
4
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
5
